Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 38, 2014 - Issue 3
271
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Screening and Diagnosis of Hb Quong Sze [HBA2: c.377T > C (or HBA1)] in a Prenatal Control Program for Thalassemia

, , , &
Pages 158-160 | Received 28 Oct 2013, Accepted 10 Dec 2013, Published online: 14 May 2014

References

  • Giardine B, Borg J, Viennas E, et al. Updates of the HbVar database of human hemoglobin variants and thalassemia mutations. Nucleic Acids Res. 2014;42(Database issue):D106-D109 (http://globin.bx.psu.edu/hbvar)
  • Goossens M, Lee KY, Liebhaber SA, Kan YW. Globin structural mutant α125 Leu → Pro is a novel cause of α-thalassaemia. Nature. 1982;296(5860):864–865
  • Liang S, Wen XJ, Lin WX. Detection of the Hb QuongSze mutation in a Chinese family by selective amplification of the α2-globin gene and restriction map analysis with MspI. Hemoglobin. 1991;15(6):535–540
  • Liao C, Li J, Li DZ. Fetal anemia and hydrops associated with homozygosity for Hemoglobin QuongSze. Prenat Diagn. 2008;28(9):862–864
  • Li DZ, Liao C, Li J, et al. Hemoglobin H hydrops fetalis syndrome resulting from the association of the – –SEA deletion and the αQuongSzeα mutation in a Chinese woman. Eur J Haematol. 2005;75(3):259–261
  • Sanchaisuriya K, Fucharoen S, Fucharoen G, et al. A reliable screening protocol for thalassemia and hemoglobinopathies in pregnancy: an alternative approach to electronic blood cell counting. Am J Clin Pathol. 2005;123(1):113–118
  • Chan LC, Ma SK, Chan AY, et al. Should we screen for globin gene mutations in blood samples with mean corpuscular volume (MCV) greater than 80 fL in areas with a high prevalence of thalassaemia? J Clin Pathol. 2001;54(4):317–320
  • Zhou YQ, Xiao GF, Li LY, et al. Evaluation of clinical application of gap-PCR as a routine method for α-thalassemia carrier detection. Di Yi Jun Yi Da Xue Xue Bao. 2002;22(5):434–436
  • Chan V, Yam I, Chen FE, Chan TK. A reverse dot–blot method for rapid detection of non-deletion α thalassaemia. Br J Haematol. 1999;104(3):513–515
  • Cao A. Carrier screening and genetic counseling in β-thalassemia. Int J Hematol. 2002;76(Suppl 2):105–113
  • Modell M, Modell B. Genetic screening for ethnic minorities. BMJ. 1990;300(6741):1702–1704
  • Li J, Li R, Zhou JY, Xie XM, et al. Prenatal control of nondeletional α-thalassemia: first experience in mainland China. Prenat Diagn. 2013;33(9):869–872
  • Karimi M, Rasekhi AR. Efficiency of premarital screening of β-thalassemia trait using MCH rather than MCV in the population of Fars Province, Iran. Haematologia (Budap). 2002;32(2):129–133
  • Langlois S, Ford JC, Chitayat D, et al. Carrier screening for thalassemia and hemoglobinopathies in Canada. J Obstet Gynaecol Can. 2008;30(10):950–971
  • Ryan K, Bain BJ, Worthington D, et al. Significant haemoglobinopathies: guidelines for screening and diagnosis. Br J Haematol. 2010;149(1):35–49
  • Liao C, Zhou JY, Xie XM, et al. Detection of Hb Constant Spring by a capillary electrophoresis method. Hemoglobin. 2010;34(2):175–178

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.